AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo
Authors: Kaushal, S Amiel, GE Guleserian, KJ Shapira, OM Perry, T Sutherland, FW Rabkin, E Moran, AM Schoen, FJ Atala, A Soker, S Bischoff, J Mayer, JE
Citation: S. Kaushal et al., Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo, NAT MED, 7(9), 2001, pp. 1035-1040
Ramzi S. Cotran, MD, 1932-2000
Authors: Schoen, FJ Gimbrone, MA
Citation: Fj. Schoen et Ma. Gimbrone, Ramzi S. Cotran, MD, 1932-2000, CARDIO PATH, 10(3), 2001, pp. 107-108
Editorial: Are immune mechanisms important in tissue heart valve failure? A debate
Authors: Schoen, FJ
Citation: Fj. Schoen, Editorial: Are immune mechanisms important in tissue heart valve failure? A debate, J HEART V D, 10(4), 2001, pp. 458-459
The homograft aortic valve: A 29-year, 99.3% follow up of 1,022 valve replacements - Meeting discussion
Authors: Yankah, C O'Brien, M Barratt-Boyes, B Schoen, FJ
Citation: C. Yankah et al., The homograft aortic valve: A 29-year, 99.3% follow up of 1,022 valve replacements - Meeting discussion, J HEART V D, 10(3), 2001, pp. 345-345
Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): Lack of correlation between phospholipase C activation and the phenotype
Authors: Mende, U Semsarian, C Martins, DC Kagen, A Duffy, C Schoen, FJ Neer, EJ
Citation: U. Mende et al., Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): Lack of correlation between phospholipase C activation and the phenotype, J MOL CEL C, 33(8), 2001, pp. 1477-1491
Comparison of two murine models of familial hypertrophic cardiomyopathy
Authors: McConnell, BK Fatkin, D Semsarian, C Jones, KA Georgakopoulos, D Maguire, CT Healey, MJ Mudd, JO Moskowitz, IPG Conner, DA Giewat, M Wakimoto, H Berul, CI Schoen, FJ Kass, DA Seidman, CE Seidman, JG
Citation: Bk. Mcconnell et al., Comparison of two murine models of familial hypertrophic cardiomyopathy, CIRCUL RES, 88(4), 2001, pp. 383-389
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves
Authors: Rabkin, E Aikawa, M Stone, JR Fukumoto, Y Libby, P Schoen, FJ
Citation: E. Rabkin et al., Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves, CIRCULATION, 104(21), 2001, pp. 2525-2532
An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro
Authors: Aikawa, M Rabkin, E Sugiyama, S Voglic, SJ Fukumoto, Y Furukawa, Y Shiomi, M Schoen, FJ Libby, P
Citation: M. Aikawa et al., An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro, CIRCULATION, 103(2), 2001, pp. 276-283
Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiationin vitro
Authors: Paranya, G Vineberg, S Dvorin, E Kaushal, S Roth, SJ Rabkin, E Schoen, FJ Bischoff, J
Citation: G. Paranya et al., Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiationin vitro, AM J PATH, 159(4), 2001, pp. 1335-1343
Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis
Authors: Jian, B Jones, PL Li, QY Mohler, ER Schoen, FJ Levy, RJ
Citation: B. Jian et al., Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis, AM J PATH, 159(1), 2001, pp. 321-327
Vascular biology of the acute coronary syndromes
Authors: Libby, P Ganz, P Schoen, FJ Lee, RT
Citation: P. Libby et al., Vascular biology of the acute coronary syndromes, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 33-57
Safety and efficacy of a steerable temperature monitoring microwave catheter system for ventricular myocardial ablation
Authors: Vanderbrink, BA Gilbride, C Aronovitz, MJ Lenihan, T Schorn, G Taylor, K Regan, JF Carr, K Schoen, FJ Link, MS Homoud, MK Estes, M Wang, PJ
Citation: Ba. Vanderbrink et al., Safety and efficacy of a steerable temperature monitoring microwave catheter system for ventricular myocardial ablation, J CARD ELEC, 11(3), 2000, pp. 305-310
A t(2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis
Authors: Vaughan, CJ Weremowicz, S Goldstein, MM Casey, M Hart, M Hahn, RT Devereux, RB Girardi, L Schoen, FJ Fletcher, JA Morton, CC Basson, CT
Citation: Cj. Vaughan et al., A t(2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis, GENE CHROM, 28(2), 2000, pp. 133-137
Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcificationby alcohol pretreatment: Further mechanistic studies
Authors: Vyavahare, NR Jones, PL Hirsch, D Schoen, FJ Levy, RJ
Citation: Nr. Vyavahare et al., Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcificationby alcohol pretreatment: Further mechanistic studies, J HEART V D, 9(4), 2000, pp. 561-566
Patch augmentation of the pulmonary artery with bioabsorbable polymers andautologous cell seeding
Authors: Stock, UA Sakamoto, T Hatsuoka, S Martin, DP Nagashima, M Moran, AM Moses, MA Khalil, PN Schoen, FJ Vacanti, JP Mayer, JE
Citation: Ua. Stock et al., Patch augmentation of the pulmonary artery with bioabsorbable polymers andautologous cell seeding, J THOR SURG, 120(6), 2000, pp. 1158-1167
Tissue-engineered valved conduits in the pulmonary circulation
Authors: Stock, UA Nagashima, M Khalil, PN Nollert, GD Herden, T Sperling, JS Moran, A Lien, J Martin, DP Schoen, FJ Vacanti, JP Mayer, JE
Citation: Ua. Stock et al., Tissue-engineered valved conduits in the pulmonary circulation, J THOR SURG, 119(4), 2000, pp. 732-740
An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
Authors: Fatkin, D McConnell, BK Mudd, JO Semsarian, C Moskowitz, IGP Schoen, FJ Giewat, M Seidman, CE Seidman, JG
Citation: D. Fatkin et al., An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy, J CLIN INV, 106(11), 2000, pp. 1351-1359
Neuroprotection mediated by changes in the endothelial actin cytoskeleton
Authors: Laufs, U Endres, M Stagliano, N Amin-Hanjani, S Chui, DS Yang, SX Simoncini, T Yamada, M Rabkin, E Allen, PG Huang, PL Bohm, M Schoen, FJ Moskowitz, MA Liao, JK
Citation: U. Laufs et al., Neuroprotection mediated by changes in the endothelial actin cytoskeleton, J CLIN INV, 106(1), 2000, pp. 15-24
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
Authors: Ducharme, A Frantz, S Aikawa, M Rabkin, E Lindsey, M Rohde, LE Schoen, FJ Kelly, RA Werb, Z Libby, P Lee, RT
Citation: A. Ducharme et al., Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction, J CLIN INV, 106(1), 2000, pp. 55-62
Early in vivo experience with tissue-engineered trileaflet heart valves
Authors: Sodian, R Hoerstrup, SP Sperling, JS Daebritz, S Martin, DP Moran, AM Kim, BS Schoen, FJ Vacanti, JP Mayer, JE
Citation: R. Sodian et al., Early in vivo experience with tissue-engineered trileaflet heart valves, CIRCULATION, 102(19), 2000, pp. 22-29
Functional living trileaflet heart valves grown in vitro
Authors: Hoerstrup, SP Sodian, R Daebritz, S Wang, J Bacha, EA Martin, DP Moran, AM Guleserian, KJ Sperling, JS Kaushal, S Vacanti, JP Schoen, FJ Mayer, JE
Citation: Sp. Hoerstrup et al., Functional living trileaflet heart valves grown in vitro, CIRCULATION, 102(19), 2000, pp. 44-49
Tissue engineering of heart valves: In vitro experiences
Authors: Sodian, R Hoerstrup, SP Sperling, JS Daebritz, SH Martin, DP Schoen, FJ Vacanti, JP Mayer, JE
Citation: R. Sodian et al., Tissue engineering of heart valves: In vitro experiences, ANN THORAC, 70(1), 2000, pp. 140-144
Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis
Authors: Bini, A Mann, KG Kudryk, BJ Schoen, FJ
Citation: A. Bini et al., Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis, ART THROM V, 19(8), 1999, pp. 1852-1861
Collaboration between the society for cardiovascular pathology (SCVP) and the international society for applied cardiovascular biology (ISACB) is justified
Authors: Schoen, FJ
Citation: Fj. Schoen, Collaboration between the society for cardiovascular pathology (SCVP) and the international society for applied cardiovascular biology (ISACB) is justified, CARDIO PATH, 8(1), 1999, pp. 53-54
Future directions in tissue heart valves: Impact of recent insights from biology and pathology
Authors: Schoen, FJ
Citation: Fj. Schoen, Future directions in tissue heart valves: Impact of recent insights from biology and pathology, J HEART V D, 8(4), 1999, pp. 350
Risultati: 1-25 | 26-39